Search research articles
Contact Us
Filters
Showing results (71-80 of 143) with videos related to
Page
of 15
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
February 1, 1991
[Mitral valvuloplasty during the 4th month of pregnancy. Fetal protection with a lead mantle]
G Drobinski, P Fraboulet, G Montalescot, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 9, 2001
Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis
J P Collet, G Montalescot, C Lesty, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
October 1, 1989
Nafamstat mesilate attenuates pulmonary hypertension in heparin-protamine reactions
E Kreil, G Montalescot, E Greene, et al.
Circulation
|
March 15, 2000
Low molecular weight heparin after mechanical heart valve replacement
G Montalescot, V Polle, J P Collet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
March 1, 1992
[Value of antimyosin monoclonal antibody scintigraphy in the diagnosis of acute myocardial infarction]
P Amoyal, G Montalescot, D Ancri, et al.
International Journal of Cardiology
|
May 31, 2002
Acute myocardial infarction after oral tranexamic acid treatment initiation
A Mekontso-Dessap, J P Collet, B Lebrun-Vignes, et al.
Clinical Cardiology
|
November 1, 1984
Lithium causing a serious sinus-node dysfunction at therapeutic doses
G Montalescot, Y Levy, D Farge, et al.
International Journal of Cardiology
|
March 31, 2012
Comparison of various methods for quantitative evaluation of myocardial infarct volume from magnetic resonance delayed enhancement data
N Baron, N Kachenoura, P Cluzel, et al.
Catheterization and Cardiovascular Diagnosis
|
February 1, 1993
Effects of ultrasound energy on thrombi in vitro
F Philippe, G Drobinski, C Bucherer, et al.
Therapeutic Drug Monitoring
|
December 16, 1998
Modeling INR data to predict maintenance fluindione dosage
E Comets, F Mentré, F Pousset, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 143) with videos related to
Sort By:
Page
of 15
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
February 1, 1991
[Mitral valvuloplasty during the 4th month of pregnancy. Fetal protection with a lead mantle]
G Drobinski, P Fraboulet, G Montalescot, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 9, 2001
Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis
J P Collet, G Montalescot, C Lesty, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
October 1, 1989
Nafamstat mesilate attenuates pulmonary hypertension in heparin-protamine reactions
E Kreil, G Montalescot, E Greene, et al.
Circulation
|
March 15, 2000
Low molecular weight heparin after mechanical heart valve replacement
G Montalescot, V Polle, J P Collet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
March 1, 1992
[Value of antimyosin monoclonal antibody scintigraphy in the diagnosis of acute myocardial infarction]
P Amoyal, G Montalescot, D Ancri, et al.
International Journal of Cardiology
|
May 31, 2002
Acute myocardial infarction after oral tranexamic acid treatment initiation
A Mekontso-Dessap, J P Collet, B Lebrun-Vignes, et al.
Clinical Cardiology
|
November 1, 1984
Lithium causing a serious sinus-node dysfunction at therapeutic doses
G Montalescot, Y Levy, D Farge, et al.
International Journal of Cardiology
|
March 31, 2012
Comparison of various methods for quantitative evaluation of myocardial infarct volume from magnetic resonance delayed enhancement data
N Baron, N Kachenoura, P Cluzel, et al.
Catheterization and Cardiovascular Diagnosis
|
February 1, 1993
Effects of ultrasound energy on thrombi in vitro
F Philippe, G Drobinski, C Bucherer, et al.
Therapeutic Drug Monitoring
|
December 16, 1998
Modeling INR data to predict maintenance fluindione dosage
E Comets, F Mentré, F Pousset, et al.
Page
of 15